A publicly traded (TSX: PLI, OTCQX: PFSCF) biopharmaceutical company specializing in bioseparation, plasma-derived therapeutics and small-molecule drug development. Offers technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens.
Manufacturers of a biological alternative to antibiotics. Explains the mechanism of action and provides company details and consumer information. Headquarters in San Ramon, California.